The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

Connection among gut fungi, genetics and disease risk in humans identified
Pharma & Human Health

Connection among gut fungi, genetics and disease risk in humans identified

SEP 19, 2025
resbiotic® Raises $14.5M to Accelerate Growth of Science-Backed Gut-X Axis Health Platform
Pharma & Human Health

resbiotic® Raises $14.5M to Accelerate Growth of Science-Backed Gut-X Axis Health Platform

SEP 16, 2025
New strains of beneficial gut bacteria discovered in animals
Animal Health

New strains of beneficial gut bacteria discovered in animals

SEP 15, 2025
CRISPR study reveals surprising role of Cas9 as a guardian of bacterial defence
GMO & Synbio

CRISPR study reveals surprising role of Cas9 as a guardian of bacterial defence

SEP 11, 2025
Persephone Biosciences Unveils First-Of-Its-Kind Synbiotic Designed To Restore Critical Gut Microbes In Babies
Biotics and Supplements

Persephone Biosciences Unveils First-Of-Its-Kind Synbiotic Designed To Restore Critical Gut Microbes In Babies

SEP 10, 2025
EXPERT’Biome, CDMO By Lallemand, Acquires Bacthera Equipment
Finance

EXPERT’Biome, CDMO By Lallemand, Acquires Bacthera Equipment

SEP 9, 2025
Novonesis and Novo Nordisk will explore new solutions to improve metabolic health
Pharma & Human Health

Novonesis and Novo Nordisk will explore new solutions to improve metabolic health

SEP 8, 2025
MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
Editor's Choice

MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline

SEP 4, 2025
New study explores effects of fungicide use on corn health and microbiome
Phytobiome & Environment

New study explores effects of fungicide use on corn health and microbiome

AUG 25, 2025
Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
Editor's Choice

Targeting the ileo-colonic region: Innovative solutions for sensitive APIs

AUG 21, 2025
SNIPR BIOME Raises EUR 35 Million Series B Financing
Finance

SNIPR BIOME Raises EUR 35 Million Series B Financing

AUG 7, 2025